SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private

BSE545.5015.5 (+2.92 %)

PREV CLOSE (Rs.) 530.00

OPEN PRICE (Rs.) 526.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 27032

TODAY'S LOW / HIGH (Rs.)526.00 548.90

52 WK LOW / HIGH (Rs.)228.25 558

NSE544.0513.15 (+2.48 %)

PREV CLOSE( Rs. ) 530.90

OPEN PRICE (Rs.) 528.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 544.05 (119)

VOLUME 374684

TODAY'S LOW / HIGH(Rs.) 526.15 549.00

52 WK LOW / HIGH (Rs.)228.5 557.7

More From Company Profile

Share Holdings

Particulars	Mar2024	Dec2023	var%	Sep2023	Jun2023	var%
Promoter and Promoter Group
Indian Promoters	50.01	50.01	0	50.01	50.01	0
Individuals / Hindu Undivided Family	50.01	50.01	0	50.01	50.01	0
Central Government/State Government(s)
Bodies Corporate
Financial Institutions / Banks
Partnership Firms
Promoter Group
Employees Welfare Fund
Other
Any Others (Specify)
Foreign Promoters
Non-Residents Individuals / Foreign Individuals
'Bodies Corporate
Institutions
Other
Any Others (Specify)
Total of Promoter and Promoter Group	50.01	50.01	0	50.01	50.01	0
Public Shareholding
Institutions	7.38	8.58	13.99	9.01	10.63	1.52
Mutual Funds / UTI	1.59	0.06	2550	0.04
Financial Institutions / Banks
Insurance Companies
Foreign Institutional Investors
Venture Capital Funds
Foreign Venture Capital Investors
Alternate Investment Funds	0.1			0.37	0.37	0
Foreign Portfolio investors	5.69	8.52	33.22	8.6	10.26	1.62
Provident funds / Pension funds
Multilateral & Bileteral Development Financial Institution
Any Others (Specify)
Central Government / State Government(s)
Foreign Financial Institutions / Banks
Stressed Assets Stabilisation Fund
Foreign Financial Institutions
State Finance Corporation
Foreign Bodies DR
Other
Non-Institutions	42.62	41.41	2.92	40.99	39.37	0.41
Bodies Corporate	11.88	13.08	9.17	12.69	8.69	4.6
Individuals
Individual shareholders holding nominal share capital up to Rs. 1 lakh	18.91	16.57	14.12	16.6	19.44	1.46
Individual shareholders holding nominal share capital in excess of Rs. 1 lakh	8.74	8.88	1.58	8.8	7.37	1.94
NBFCs Registed with RBI
Employee Trusts
Any Others (Specify)	1.02	0.97	5.15	0.92	1.05	1.24
Clearing Members	0.01				0.03	10
Non Resident Indians	1.73	1.56	10.9	1.63	2.47	3.4
Directors & their Relatives & Friends	0.04	0.04	0	0.04	0.04	0
Foreign Collaborators
Foreign Mutual Fund
Trusts
Hindu Undivided Families	1.01	0.97	4.12	0.92	1.02	0.98
Foreign Corporate Bodies
Shares in transit
Market Maker
ESOP/ESOS/ESPS
Societies
Escrow Account
Any Other	0.31	0.31	0	0.3	0.3	0
Total Public Shareholding	49.99	49.99	0	49.99	49.99	0

Total of Promoter and Public Shareholding	100	100	0	100	100	0

Shares held by Custodians and against which Depository Receipts have been issued
American Depository Receipts
GDRs
Others

Grand Total	100	100	0	100	100	0

ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING

Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.

ATTENTION INVESTORS Advisory for Investors Advisory - KYC Compliance

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
3. Pay 20% upfront margin of the transaction value to trade in cash market segment.
4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors

CORPORATE OFFICE

address

9/2003-4,
Vishnu Priya Limda Chowk
Main Road
Surat – 395 003.

call us @ +91-261-6673500 +91-261-2436536

fax us @ +91-261-6673537

email us @ info@rwadiwala.com

BSE, NSE, MCX SEBI Regn no.: INZ000187332 | PMS SEBI Regn no.: INP000004045 | CDSL SEBI Regn No.: IN-DP-112-2015 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage.

SHILPA MEDICARE LTD.

Share Holdings

Filing complaints on SCORES Easy & quick